T1	Participants 357 459	231 non-insulin-dependent diabetic men with either a recent amputation for gangrene or active gangrene
T2	Participants 596 693	24 atherosclerotic deaths in the drug treatment group (21.8%) and 23 in the placebo group (19.0%)
T3	Participants 706 829	22 patients in the drug treatment group (20.0%) and 29 patients in the placebo group (24.0%) with opposite-side amputations
